GlassScriptPhysician profile
Stephen H Weinstein
NPI 1912950098
$3,313.59
in general payments reported to CMS, 2019-2025
15 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2020: $110 · 2021: $540 · 2022: $865 · 2023: $631 · 2024: $545 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,142 · Education: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,142.32 |
| Education | $232.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,388.24 | 2019-2025 | Lithovue |
| Coloplast Corp | $805.83 | 2021-2025 | Speedicath, Titan |
| Astellas Pharma US INC | $581.17 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $85.50 | 2023 | Lynparza |
| Stryker Corporation | $75.86 | 2023 | 1788 |
| Janssen Biotech, INC. | $73.68 | 2019 | |
| Axonics, INC. | $57.75 | 2023 | Axonics |
| Teleflex LLC | $52.30 | 2024 | |
| Cook Medical LLC | $43.93 | 2019 | |
| Rochester Medical Corporation | $37.44 | 2022 | |
| Photocure INC | $34.16 | 2019 | |
| Laborie Medical Technologies Corp. | $26.92 | 2023 | |
| 180 Medical, INC. | $26.91 | 2020 | |
| Karl Storz Endoscopy-America | $22.80 | 2019 | |
| Travere Therapeutics, INC. | $1.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.